PRF1 and neoplasm: The reduced cytotoxicity of NK cells as reported in COVID-19 patients is often concluded from decreased levels of perforin and granzymes or from decreased degranulation as analysed by CD107a expression after stimulation with tumour target cells (19, 28–30).